INSTRUCTIONS FOR MEDICAL USE
Trade name of the drug: Mumiyo Asil®.
Active ingredient: mumiyo. Mumiyo (termed there Mumie or Mumijo), India (Saljit), Birma (Kao-tun) (blood of the mountain)
Dosage form: 150 mg capsules.
1 capsule contains:
active substance: purified mumiyo – 150 mg;
Excipients: potato or corn starch, calcium or magnesium stearate, sugar.
Description: hard, gelatin capsules, color orange, filled with brown to black powder with light colored flecks, with a characteristic odor.
Pharmacotherapeutic group: tissue trophism and regeneration stimulator.
ATX code: M09AX
Mumiyo as a natural biostimulant, known in Oriental medicine for over three thousand years. Mumiyo is a product of natural origin and consists of bioorganomineral compounds – micro and macro elements, amino acids, vitamins B and P, steroids, polyphenolic compounds, etc. Mumiyo, as an active biostimulant, has regenerative properties, especially in relation to the bone tissue, accelerates bone fracture healing, bone growth in chronic injuries and osteomyelitis. It also has anti-inflammatory, antiseptic, immunostimulatory, tonic and tonic effect.
Indications for use
Mumiyo used in the treatment of fractures of bones, especially with delayed consolidation, osteomyelitis, exacerbation of chronic bronchitis (including obstructive), to accelerate regeneration in gastric ulcers and duodenal ulcers. Mumiyo capsules are also used to enhance the body’s defense against bacterial infections and other environmental factors, as a general tonic and tonic.
Method of administration and dosage
Mumiyo is prescribed inside 1 capsule 3 times: in the morning on an empty stomach, during lunch 1 hour before a meal, in the evening 1-2 hours after a meal, before going to bed. Capsules should preferably be taken with milk, honey or water. The course of treatment is 2 weeks. If necessary, after 10 days, you can repeat the treatment under the supervision of a physician. Depending on the nature and severity of the disease appointed 1-5 courses (for fractures and osteomyelitis at least 2 courses).
Have not been identified.
Individual intolerance to the drug, expressed respiratory or cardiac insufficiency. Mumiyo capsules are not recommended for use in very high blood pressure, during severe bleeding of various origins, hemophilia, pregnancy and lactation, children under 12 years of age.
It is not described.
Use with caution in hypertension and hemophilia. During treatment it is not recommended to drink alcoholic beverages. Breast-feeding should be discontinued while taking the drug.
It is not described.
Form of production
Capsules, 150 mg, №10, №20 (2×10), №30 (3×10) in carton packs, or №10, №20, №30, №40, №50, №60 in jars.
In a dry, dark place at a temperature not exceeding 25 ° C. Keep away from children!
2 years. Do not use after the expiration date.
Conditions of dispensing from pharmacies
Released without a prescription.